WEBINAR ENDED
WEBINAR DETAILS
  • When
    Copenhagen (GMT 2:00)
  • About
    Based on the publication of the Q1 2021 Interim Report earlier the same day, the senior Management Team will offer a walkthrough of the report contents and answer pre-submitted questions from the audience.

    At this presentation, the CEO will also present the investment case of the company as it is presented in the prospectus for the ongoing Rights Issue.

    Pre-submitted questions will be prioritized. To submit a question, please send it to investorrelations@allarity.com, no later than 2:30 pm on 28 May.

    Allarity Therapeutics is building a personalized medicine company developing new therapeutics for unmet needs in the treatment of human cancers through the use of the company's world-class predictive diagnostics platform.
  • Agenda
    • General and Operational Status by the CEO
    • Financials by the CFO
    • Rights Issue
    • Q&A
  • Price
    Free
  • Language
    English
  • OPEN TO
    Anyone with the event link can attend
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS